Literature DB >> 185239

Hepatic lesions in patients treated with synthetic anabolic steriods.

E C Sweeney, D J Evans.   

Abstract

Hepatic abnormalities are described in three patients who received synthetic anabolic steroids. A child with Franconi's anaemia was treated for four years and at necropsy the liver showed generalized hyperplasia, hyperplastic nodules, and a benign hepatoma. Two adults received only three months' therapy with synthetic androgens; in one there was generalized hepatic hyperplasia and in the other widespread nodular hyperplasia. It is suggested that anabolic steroids may induce tumours through intermediate hyperplastic lesions, a sequence similar to that seen during tumour induction by carcinogens in experimental animals.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 185239      PMCID: PMC476130          DOI: 10.1136/jcp.29.7.626

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Non-cirrhotic portal hypertension in Felty's syndrome.

Authors:  E C Sweeney
Journal:  Ir J Med Sci       Date:  1975-04       Impact factor: 1.568

Review 2.  Hepatoma associated with androgen therapy for aplastic anemia.

Authors:  A T Meadows; J L Naiman; M Valdes-Dapena
Journal:  J Pediatr       Date:  1974-01       Impact factor: 4.406

3.  FANCONI'S ANEMIA AND HEPATIC CIRRHOSIS.

Authors:  J E SOKAL; D FIRAT
Journal:  Am J Med       Date:  1965-09       Impact factor: 4.965

4.  Miliary hepatocellular adenomatosis.

Authors:  S RANSTROM
Journal:  Acta Pathol Microbiol Scand       Date:  1953

5.  Letter: Liver tumours and steroid hormones.

Authors:  D Cattan; P Vesin; J Wautier; R Kalifat; S Meignan
Journal:  Lancet       Date:  1974-05-04       Impact factor: 79.321

6.  Androgenic-anabolic steroid therapy and hepatocellular carcinoma.

Authors:  J T Henderson; J Richmond; M D Sumerling
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

7.  Androgens and hepatocellular carcinoma.

Authors:  J Ziegenfuss; R Carabasi
Journal:  Lancet       Date:  1973-02-03       Impact factor: 79.321

8.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

Authors:  F L Johnson; K G Lerner; M Siegel; J R Feagler; P W Majerus; J R Hartmann; E D Thomas
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

9.  Androgenic steroids and hepatocellular carcinoma.

Authors:  J T Guy; M O Auslander
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

10.  Squamous cell carcinomas in Fanconi's anemia.

Authors:  M Swift; D Zimmerman; E R McDonough
Journal:  JAMA       Date:  1971-04-12       Impact factor: 56.272

View more
  6 in total

1.  Danazol-Induced Hepatocellular Carcinoma in a Patient with Hereditary Angioedema.

Authors:  Muhammed Hameed Thoufeeq; Javaid Ishtiaq; Mohamed Abuzakouk
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Abnormal sex-steroid milieu in young adults with hepatocellular carcinoma.

Authors:  R A Malt; J J Galdabini; B W Jeppsson
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

Review 3.  Adverse effects of anabolic steroids.

Authors:  R C Hickson; K L Ball; M T Falduto
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

4.  Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.

Authors:  Andreas Palagyi; Kornelia Neveling; Ursula Plinninger; Andreas Ziesch; Bianca-Sabrina Targosz; Gerald U Denk; Stephanie Ochs; Antonia Rizzani; Daniel Meier; Wolfgang E Thasler; Helmut Hanenberg; Enrico N De Toni; Florian Bassermann; Claus Schäfer; Burkhard Göke; Detlev Schindler; Eike Gallmeier
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

Review 5.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

6.  The role of anabolic hormones for wound healing in catabolic states.

Authors:  Robert H Demling
Journal:  J Burns Wounds       Date:  2005-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.